Is post-prandial lipaemia an independent risk factor for atherosclerosis?
Professor Henry Ginsberg (Co-Chair)Watch the presentation >
What can we learn from kinetic studies of ANGPTL3-loss of function variants, and how do their effects compare to those of apoC3-LOF variants?
Professor Jan BorénWatch the presentation >
Update on novel apoC3-targeted therapeutics in hypertriglyceridaemia
Dr Nicholas MarstonWatch the presentation >
Complete loss of apoC3 function: Effects on apoB-containing lipoprotein metabolism
Professor Daniel RaderWatch the presentation >
Adipose tissue-liver crosstalk: Implication of ANGPTL4 inhibition
Dr Sander KerstenWatch the presentation >
Effects of omega-3 fatty acids, fibrates and PCSK9 inhibitors on plaque composition, burden and stability: Insights from imaging
Dr Matthew Jay BudoffWatch the presentation >
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
